期刊文献+

缺氧后内皮细胞早期生长反应因子-1活化的信号机制

The Signaling Mechanism Involved in Hypoxia-induced Upregulation of Early Growth Response-1 in Endothelial Cells
下载PDF
导出
摘要 目的观察缺氧对内皮细胞早期生长反应因子(Egr-1)表达的影响及晚期糖基化终末产物(AGEs)及其受体(RAGE)对上述效应的可能调控机制。方法以培养小鼠主动脉内皮细胞(MAECs)为模型,根据缺氧时间和缺氧前预处理方式,分为不同缺氧时间组[缺氧0(对照组),5,10,15,30,60,120min组]、anti-AGE预处理组、可溶性RAGE(sRAGE)预处理组和蛋白激酶C(PKC)β抑制剂组,实时定量PCR法检测缺氧后Egr-1mRNA含量、ELISA法检测细胞裂解液中AGEs含量、蛋白印迹法检测细胞膜蛋白中PKC各异构体的活化。结果缺氧15min组Egr-1mRNA表达上调,为对照组的(14.13±0.77)倍(P=0.0000);缺氧10~60min内皮细胞裂解液中AGEs堆积;缺氧15min组MAECs膜蛋白中PKCβⅡ含量为(30.57±1.86),显著高于对照组的含量(9.22±1.05)(P=0.002);anti-AGE、sRAGE和PKCβ抑制剂预处理减少缺氧诱导的Egr-1 mRNA表达上调(P=0.0000);anti-AGE和sRAGE预处理显著减少缺氧对PKCβⅡ的活化(P=0.0000)。结论急性缺氧诱导内皮细胞AGEs堆积、PKCβⅡ活化和Egr-1mRNA高表达,AGEs-RAGE和PKCβII信号参与急性缺氧后Egr-1诱导表达的调控。 Objective To observe the impact of hypoxia on the expression of early growth response-l(Egr-1) in mouse aortic endothelial cells(MAECs), and to study the underlying signaling mech- anism involving advanced glycation end-products (AGEs) and its receptor (receptor for AGEs, RAGE). Methods MAECs were subjected to hypoxia treatment with a (6.0±0.5) %oxygen concentration for va- rious periods (0, 5, 10, 15, 30, 60 or 120 min), or were first pre-incubated with anti-AGEs or soluble RAGE (sRAGE) for 2 h, or LY379196 for 45 min respectively, and then subsequently exposed to hypoxia for 15 min. Egr-1 mRNA levels were detected by real time PCR (RT-PCR), AGEs in cell lysate were monitored by ELISA, and PKC isoformates in membrane fraction were examined by western blot. MAECs cultured with normoxia were used as controls. Results With 15-minute hypoxic exposure, Egr- 1 mRNA level in MAECs was (14.13±0.77) folds higher compared with normoxic controls (P=0. 000 0). Within 10-60 minutes hypoxic exposure, AGEs were accumulated in MAECs lysate. With 15-minute hypoxic exposure, PKCI3II in membrane fraction is (30.57 ±1.86) vs (9.22± 1.05) arbitrary units com- pared with normoxic controls (P=0. 002). Hypoxia-induced Egr-1 mRNA expression was decreased by pre-incubation with anti-AGE, sRAGE or PKCβII inhibitor (P = 0. 000 0). Hypoxia-induced PKCI3II activation was attenuated by pre-incubation with anti-AGE or sRAGE (P = 0. 000 0). Conclusions In MAECs, acute hypoxia induced AGEs accumulation, PKCβII activation and Egr-1 mRNA expression. AGEs-RAGE and PKCI3II signaling pathway were involved in hypoxia-induced Egr-1 mRNA expression. These findings highlight these signaling molecules as potential therapeutic targets to protect tissue injury by acute hypoxia.
出处 《福建医科大学学报》 2012年第4期227-230,共4页 Journal of Fujian Medical University
基金 福建省自然科学基金(2009J01144) 福建省卫生厅医学创新课题(2009-CXB-18)
关键词 缺氧 晚期糖基化终末产物受体 早期生长反应因子-1 蛋白激酶C 内皮细胞 RNA 信使 hypoxia receptor for advanced glycation end products early growth response-i pro-tein kinase C endothelial cells RNA, messenger
  • 相关文献

参考文献12

  • 1YanS F,FujitaT,Lu J,etal. Egr-1, a master switch coordi- nating regulation of divergent gene families underlying ischemic stress[J]. ,NutMed, 2000,6(12):1355-1361.
  • 2Zeng S,Dun H,Ippagunta N,etal. Receptor for advancedgly- cation end product (RAGE)-dependent modulation of early growth response-1 in hepatic isehemia/reperfusion injury [J]. J Hepatol, 2009,50(5):929 936.
  • 3Fujita T, Asai T, Andrassy M,et al. PKCbeta regulates ische- mia/reperfusion injury in the lung[J]. J Clin Invest, 2004, 113(11) : 1615-1623.
  • 4Huang C,Chang J S,Xu Y,et al. Reduction of PKCbetaII ac- tivity in smooth muscle ceils attenuates acute arterial injury [J]. Atherosclerosis, 2010,212(1) ..123-130.
  • 5Ramasamy R, Yan S F, Schmidt A M. Receptor for AGE (RAGE) signaling mechanisms in the pathogenesis of diabe- tes and its complications [J]. N Y Acad Sci, 2011, 1243: 88-102.
  • 6Kobayashi M, Inoue K,Warabi E, et al. A simple method of isolating mouse aortic endothelial cells [J]. J Atheroscler Thromb, 2005,12(3) :138 142.
  • 7吴文伟,黄春.蛋白激酶Cβ介导急性股动脉损伤后基质金属蛋白酶9的活化[J].中华老年医学杂志,2011,30(7):589-592. 被引量:6
  • 8Kong L H, Andrassy M, Chang J S,et al. PKC1] modulates ischemia-reperfusion injury in the heart[J]. Am J PhysiolHeart Circ Physiol, 2008,294 : 1862-1870.
  • 9Bhindi R,Fahmy R G,McMahon A C,et al. Intracoronary de livery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion[J]. J Pathol, 2012,227(2), 157-164.
  • 10Ramasamy R,Schmidt A M. Receptor for advanced glycation end products(RAGE) and implications for the pathophysiolo- gy of heart failure[J]. Curt Heart Fail Rep, 2012,9 (2) 107-116.

二级参考文献8

  • 1Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Phamacol, 2008, 75: 346-359.
  • 2Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res, 2003, 92: 827-839.
  • 3Katsaros KM, Kastl SP, Zorn G, et al. Increase restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase 2 and -9. JACC Cardiovasc Interv, 2010, 3: 90-97.
  • 4Ge JB, Shen CX, Liang C, et al. Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. Int J Cardiol, 2006, 112: 85-90.
  • 5Roque M,John T, Juan FJ, et al. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vascr Biol, 2000,20 : 335-342.
  • 6Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev, 2006,58: 358-376.
  • 7Li C, Wernig F, Leitges M, et al. Mechanical stress-activated PKC delta regulates smooth muscle migration. FASEB J, 2003, 17: 2106-2108.
  • 8Eitges M, Mayr M, Braun U, et al. Exacerbated vein graft arteriosclerosis in protein kinase C delta mice. J ClinInvest, 2001, 108: 1505-1512.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部